GeneDx: A Diagnostic Company’s Stock Takes a Hit Amidst Earnings Beat and Guidance Raise
As of this writing, GeneDx (WGS) stock has plummeted 39.3% in morning trading after the company reported its first-quarter earnings results that beat expectations but failed to meet investors’ lofty hopes. GeneDx is a health intelligence company specializing in exome and genome testing for genetic disease diagnosis. The company’s platform helps screen patients’ DNA for … Read more
https://www.profitablecpmrate.com/nsirjwzb79?key=c706907e420c1171a8852e02ab2e6ea4
Skip to content